Found 2 clinical trials
New Daily Persistent Headache Biomarkers Study
The goal of this study is to evaluate the blood levels of two proteins involved with pain signaling; calcitonin gene-related peptide (CGRP) and nerve growth factor (NGF). CGRP levels are known to be elevated in chronic migraine, and recent phase 2 clinical trials suggest that treatments targeting CGRP are safe …
- 0 views
- 16 Feb, 2024
- 1 location
Validation of a Novel Cortical Biomarker Signature for Pain
The study aims to undertake analytical validation of an brain biomarker in healthy participants experiencing a model of sustained temporomandibular pain. The biomarker could detect participants at greater risk of developing more severe pain.
- 0 views
- 16 Feb, 2024
- 2 locations